FDA Approves Clinical Trials for ZW171: A Novel Bispecific Antibody for Hard-to-Treat Cancers

FDA Approves Grifols' Yimmugo® for Primary Immunodeficiency, Marking a Milestone

ASCO24: Opdivo Plus Yervoy Significantly Improves Overall Survival in Liver Cancer

AbbVie Reveals Promising ADC Data for Advanced Cancer Treatments at ASCO 2024

GenFleet's Fulzerasib Combo Achieves 81.8% Response Rate in Lung Cancer Treatment

Tagrisso Extends Survival in Stage III EGFR-Mutated Lung Cancer Treatment

Scemblix® Outperforms Standard Treatments in Phase III Myeloid Leukemia Trial

Spinogenix's Daily Pill SPG302 Receives FDA IND Nod for ALS Treatment

How Focused Ultrasound Could Change Treatment Options for Brain Cancers

Genomic Testing Transforms Breast Cancer Care and Treatment Success

Zai Lab Advances Psoriasis Treatment with ZL-1102 Topical Therapy in Phase 2 Trial

New Treatment for AA Hepatitis: Larsucosterol Earns FDA Breakthrough Designation

The Impact of CAR-T Cell Therapies on the Future of Pediatric Cancer Care

Nimbus Reports Early Success in Treating Solid Tumors with NDI-101150, an HPK1 Inhibitor

Safer Non-Opioid Pain Relief on the Horizon: SRP-001 Shows Promise in Phase 1 Trials

Beyond Visualization: The Promise of VGT-309 in Minimally Invasive Lung Cancer Surgery

FDA Approves IMDELLTRA for Lung Cancer After a 40% Response Rate

Pfizer Reports Promising Survival Benefits in Vepdegestrant Trial for Breast Cancer

Advancing Hepatitis B Cure: A Closer Look at Barinthus Bio's VTP-300 Project

A New Horizon in Oncology: FDA Approves the First-Ever mRNA Cancer Vaccine

Can Artificial Intelligence Help Bridge the Gap in Healthcare Tech Skills?

How Ring's Anellovectors Could Change the Treatment of Genetic Diseases

Oregon & Lantern Pharma's Strategic AI Collaboration to Enhance Cancer Drug

TAR-210 Study Shows Promise in Bladder Cancer Treatment with 90% RF Survival Rate

Novartis Expands Radioligand Therapy Portfolio with $1B Acquisition of Mariana

KEYTRUDA Shows Promising Survival Benefits in Gastric Cancer: Phase 3 Trial

Monteris Introduces Smallest NB3 Laser Probe for Brain Tumor Surgery

FDA Grants Full Approval for Tivdak® to Treat Recurrent or Metastatic Cervical Cancer

GenFleet Receives FDA Approval for P3 Trial of GFH925 in Colorectal Cancer Treatment

Transformative One-Time Gene Therapy: FDA Approves Pfizer's BEQVEZ, for Hemophilia B